Oncotelic Therapeutics OTLC
OTC OTLC
$0.01 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Oncotelic Therapeutics (OTLC) Long-Term Debt Repayments (2021 - 2022)

Updated

Oncotelic Therapeutics (OTLC) reported Long-Term Debt Repayments of $440,000 for Q2 2022, up 780.0% from $50,000 a year earlier and up 633.3% from the prior quarter.

Analysis

Oncotelic Therapeutics (OTLC) Long-Term Debt Repayments (2021 - 2022) Analysis & Trends

For FY2021, Oncotelic Therapeutics posted Long-Term Debt Repayments of $100,000, up 100.0% from FY2020.

  • By year, Long-Term Debt Repayments came in at $50,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 1.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -4.91 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Oncotelic Therapeutics 5.77 Mn 4.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -60,000.00
Dec 31, 2021 307,500.00
Jun 30, 2021 50,000.00
Mar 31, 2021 50,000.00
API Access

Oncotelic Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=OTLC&period=max&api_key=YOUR_API_KEY